loadpatents
Patent applications and USPTO patent grants for BETAGERI; Guru V..The latest application filed is for "proliposomal testosterone undecanoate formulations".
Patent | Date |
---|---|
Proliposomal Testosterone Undecanoate Formulations App 20220265679 - KADAJJI; Veeran Gowda ;   et al. | 2022-08-25 |
Formulations for treating bladder cancer Grant 11,229,602 - Betageri , et al. January 25, 2 | 2022-01-25 |
Liposomal Enhanced Intra-peritoneal Chemotherapy App 20220000777 - OEFELEIN; Michael G. ;   et al. | 2022-01-06 |
Formulations For Treating Bladder Cancer App 20210267896 - BETAGERI; Guru V. ;   et al. | 2021-09-02 |
Liposomal Paclitaxel Formulation For Treating Bladder Cancer App 20200170993 - OEFELEIN; Michael G. ;   et al. | 2020-06-04 |
Methods Of Treating Upper Tract Urothelial Carcinomas App 20190343763 - BETAGERI; Guru V. ;   et al. | 2019-11-14 |
Proliposomal Testosterone Undecanoate Formulations App 20190248830 - BETAGERI; Guru V. ;   et al. | 2019-08-15 |
Novel Formulation Of Pegylated-liposome Encapsulated Glycopeptide Antibiotics App 20190133946 - PUMERANTZ; Andrew ;   et al. | 2019-05-09 |
Formulations For Treating Bladder Cancer App 20190015334 - BETAGERI; Guru V. ;   et al. | 2019-01-17 |
Ternary Mixture Formulations App 20180311166 - BETAGERI; Guru V. ;   et al. | 2018-11-01 |
Proliposomal Testosterone Formulations App 20180303850 - BETAGERI; Guru V. ;   et al. | 2018-10-25 |
Proliposomal testosterone formulations Grant 9,844,557 - Betageri , et al. December 19, 2 | 2017-12-19 |
Ternary mixture formulations Grant 9,808,426 - Betageri , et al. November 7, 2 | 2017-11-07 |
Novel Formulation Of Pegylated-liposome Encapsulated Glycopeptide Antibiotics App 20170231912 - PUMERANTZ; Andrew ;   et al. | 2017-08-17 |
Ternary Mixture Formulations App 20170128368 - BETAGERI; Guru V. ;   et al. | 2017-05-11 |
Proliposomal testosterone formulations Grant 9,623,033 - Betageri , et al. April 18, 2 | 2017-04-18 |
Proliposomal Testosterone Formulations App 20170065614 - BETAGERI; Guru V. ;   et al. | 2017-03-09 |
Proliposomal Testosterone Formulations App 20160375036 - BETAGERI; Guru V. ;   et al. | 2016-12-29 |
Ternary mixture formulations Grant 9,492,387 - Betageri , et al. November 15, 2 | 2016-11-15 |
Proliposomal testosterone formulations Grant 9,445,995 - Betageri , et al. September 20, 2 | 2016-09-20 |
Proliposomal Testosterone Formulations App 20150157572 - Betageri; Guru V. ;   et al. | 2015-06-11 |
Coated Drug Delivery Formulations App 20150140092 - BETAGERI; Guru V. | 2015-05-21 |
Proliposomal testosterone formulations Grant 8,957,053 - Betageri , et al. February 17, 2 | 2015-02-17 |
Coated drug delivery formulations Grant 8,889,180 - Betageri November 18, 2 | 2014-11-18 |
Proliposomal Testosterone Formulations App 20140112986 - BETAGERI; Guru V. ;   et al. | 2014-04-24 |
Coated drug delivery formulations Grant 8,658,202 - Betageri February 25, 2 | 2014-02-25 |
Ternary Mixture Formulations App 20130310397 - Betageri; Guru V. ;   et al. | 2013-11-21 |
Coated Drug Delivery Formulations App 20120027864 - BETAGERI; Guru V. | 2012-02-02 |
Liposome Drug Delivery App 20090123530 - Betageri; Guru V. ;   et al. | 2009-05-14 |
Liposome drug delivery Grant 7,387,791 - Betageri , et al. June 17, 2 | 2008-06-17 |
Coated drug delivery formulations App 20050152965 - Betageri, Guru V. | 2005-07-14 |
Enteric-coated proliposomal formulations for poorly water soluble drugs App 20050031687 - Betageri, Guru V. | 2005-02-10 |
Proliposomal drug delivery system Grant 6,849,269 - Betageri February 1, 2 | 2005-02-01 |
Liposome drug delivery App 20050008688 - Betageri, Guru V. ;   et al. | 2005-01-13 |
Liposome drug delivery Grant 6,761,901 - Betageri , et al. July 13, 2 | 2004-07-13 |
Enteric-coated proliposomal formulations for poorly water soluble drugs Grant 6,759,058 - Betageri July 6, 2 | 2004-07-06 |
Proliposomal drug delivery system App 20020187189 - Betageri, Guru V. | 2002-12-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.